Kupper Wintergerst
Pediatric Endocrinology · Louisville, KYNPI 1124159009
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $201,528 of the $313,054 with a category attached, or 64.4%. Sanofi-aventis U.S. LLC accounts for 90.2% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $153,561, more than ten times the $252 reported in 2019.
Across 213 payments — averaging $1469.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$282K
- Sanofi$26K
- Mannkind Corporation$2K
- Bayer$914
- Novo Nordisk$794
- Tandem Diabetes Care, Inc.$331
- plus $842 from 7 others
Across 1,126 payments — averaging $1324.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mannkind Corporation$859K
- Boehringer Ingelheim$412K
- Novo Nordisk AS$85K
- Boehringer Ingelheim Pharma GmbH & Co.kg$65K
- Dompe Farmaceutici S.p.a.$48K
- Boehringer Ingelheim France S.a.s.$12K
- plus $9K from 4 others
What the payments were for
- Consulting fees$82,97027%
- Speaking & faculty fees$201,52864%
- Travel & lodging$21,0027%
- Food & beverage$7,3612%
- Education$1940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 174 | $282,335 |
| Sanofi | 11 | $25,873 |
| Mannkind Corporation | 5 | $1,964 |
| Bayer | 1 | $914 |
| Novo Nordisk | 11 | $794 |
| Tandem Diabetes Care, Inc. | 4 | $331 |
| Neurocrine Biosciences, Inc. | 1 | $131 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Ascendis Pharma Endocrinology Inc | 1 | $125 |
| Abbott | 1 | $124 |
| Ultragenyx Pharmaceutical Inc. | 1 | $120 |
| Shire North American Group Inc | 1 | $112 |
| Medtronic | 1 | $106 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$234,150
- TOUJEO$18,837
- AFREZZA$1,900
- Vitrakvi$914
- Wegovy$266
- t-slim insulin pump$139
- CRENESSITY$131
- NEXLIZET$125
- NEXLETOL$125
- Yorvipath$125
- FreeStyle Libre$124
- CRYSVITA$120
- MINIMED 780G$106
- Sogroya$102
How this compares
Too few pediatric endocrinology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Louisville
- Lisal FolsomLouisville$16K
- Catalina Cabrera-SalcedoLouisville$1K
- Susan RaghavanLouisville$864
- Bradly ThrasherLouisville$478
- Michael FosterLouisville$337
- Sara WatsonLouisville$249
- Adetokunbo OmoruyiLouisville$114
- Megan CoriellLouisville$100
- Aurelia WoodLouisville$13
- Sarah SwaugerLexington$371
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.